These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30259557)

  • 1. Bayesian knowledge integration for an in vitro-in vivo correlation model.
    Erhardt EM; Ursino M; Biewenga J; Jacobs T; Gasparini M
    Biom J; 2019 Sep; 61(5):1104-1119. PubMed ID: 30259557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1-step Bayesian predictive approach for evaluating in vitro in vivo correlation (IVIVC).
    Gould AL; Agrawal NG; Goel TV; Fitzpatrick S
    Biopharm Drug Dispos; 2009 Oct; 30(7):366-88. PubMed ID: 19735073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating In Vivo-In Vitro Correlation Using a Bayesian Approach.
    Qiu J; Martinez M; Tiwari R
    AAPS J; 2016 May; 18(3):619-34. PubMed ID: 26896256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.
    Kesisoglou F; Xia B; Agrawal NG
    AAPS J; 2015 Nov; 17(6):1492-500. PubMed ID: 26290380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level A in vitro-in vivo correlation (IVIVC) model with Bayesian approach to formulation series.
    Kortejärvi H; Malkki J; Marvola M; Urtti A; Yliperttula M; Pajunen P
    J Pharm Sci; 2006 Jul; 95(7):1595-605. PubMed ID: 16732564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an NLME-Stochastic Deconvolution Approach to Level A IVIVC Modeling.
    Kakhi M; Suarez-Sharp S; Shepard T; Chittenden J
    J Pharm Sci; 2017 Jul; 106(7):1905-1916. PubMed ID: 28341596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Sci; 2001 Aug; 90(8):1176-85. PubMed ID: 11536222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro-In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone.
    Tosca EM; Rocchetti M; Pérez E; Nieto C; Bettica P; Moscoso Del Prado J; Magni P; De Nicolao G
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33673306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Level a In Vitro-In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study.
    Lee DY; Shin S; Kim TH; Shin BS
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convolution-based approaches for in vivo-in vitro correlation modeling.
    Gillespie WR
    Adv Exp Med Biol; 1997; 423():53-65. PubMed ID: 9269483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
    Vuletić L; Khan MZI; Špoljarić D; Radić M; Cetina-Čižmek B; Filipović-Grčić J
    Pharm Res; 2018 Jun; 35(8):163. PubMed ID: 29934663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of level A in vitro-in vivo correlations for an extended-release formulation with limited bioavailability.
    Kakhi M; Marroum P; Chittenden J
    Biopharm Drug Dispos; 2013 Jul; 34(5):262-77. PubMed ID: 23097186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-In vivo Relationship and Bioequivalence Prediction for Modified-Release Capsules Based on a PBPK Absorption Model.
    Jereb R; Opara J; Legen I; Petek B; Grabnar-Peklar D
    AAPS PharmSciTech; 2019 Dec; 21(1):18. PubMed ID: 31820131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
    Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
    J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.
    Mittapalli RK; Nuthalapati S; Delke DeBord AE; Xiong H
    Pharm Res; 2017 Jun; 34(6):1187-1192. PubMed ID: 28243955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine Transdermal Patch: Pharmacokinetic Modeling and In Vitro-In Vivo Correlation (IVIVC).
    Kondamudi PK; Tirumalasetty PP; Malayandi R; Mutalik S; Pillai R
    AAPS PharmSciTech; 2016 Jun; 17(3):588-96. PubMed ID: 26283198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
    Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
    Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.